Baba Ramdev introduced colonil Ayurvedic medicine for COVID-19 Coronavirus treatment: Ramdev's launches Coronil kit

Yoga guru Ramdev-run Patanjali Ayurved on Tuesday launched Coronil and Swasari, an Ayurvedic medicine, for fit against COVID-19 and increas immune system 

to assist treat the novel coronavirus or Covid-19 infection on Tuesday at Patanjali Yogpeeth in Haridwar, Uttarakhand



During the launch, Baba Ramdev said that the drugs has shown '100 per cent recovery rate within 3-7 days'. Baba Ramdev had revealed that COVID-19 patients who got Coronil - which is formed from a mix of Ashwagandha, Giloy and Tulsi - showed 100 per cent recovery rate. Coronil is that the first evidence-based ayurvedic medicine for coronavirus contagion. 

the drugs has been developed in joint research by Patanjali Research Insitute, National Institue of life science , Jaipur. Almost 500 scientists of the Patanjali worked tirelessly to seek out a cure for coronavirus. Patanjali's Chief military officer (CEO), Acharya Balkrishna, had earlier claimed that the corporate has found a cure for was ready to cure a minimum of 1,000 coronavirus patients within 5-14 days. 


consistent with the corporate they need conducted 'randomized placebo-controlled clinical trials' and through the conference, they're going to reveal the result of the test. 

"We appointed a team of scientists after the Covid-19 outbreak. First, the simulation was done and compounds were identified which may fight the virus and stop its spread within the body.

 Then, we conducted a clinical case study on many positive patients and that we have gotten 100 per cent favourable results. We aren't talking about an immunity booster. 


We are talking a few cure," Patanjali CEO Acharya  said in Haridwar, consistent with ANI. aside from Patanjali,

 three other drugs were launched by Indian pharma companies for emergency care of Covid-19 patients. On Saturday Glenmark Pharmaceuticals launched the antiviral Favipiravir under the name Fabiflu, and it had been followed by the launch of the anti-viral drug Remdesivir by pharma companies Cipla and Hetero under the name Cipremi and Covifor respectively. When will it's available? this may be available in 8 to 10